Tranexamic acid for significant traumatic brain injury (The CRASH-3 trial): Statistical analysis plan for an international, randomised, double-blind, placebo-controlled trial

Background: Worldwide, traumatic brain injury (TBI) kills or hospitalises over 10 million people each year. Early intracranial bleeding is common after TBI, increasing the risk of death and disability. Tranexamic acid reduces blood loss in surgery and death due to bleeding in trauma patients with ex...

Descripción completa

Detalles Bibliográficos
Autores principales: Roberts, Ian, Belli, Antonio, Brenner, Amy, Chaudhri, Rizwana, Fawole, Bukola, Harris, Tim, Jooma, Rashid, Mahmood, Abda, Shokunbi, Temitayo, Shakur, Haleema
Formato: Online Artículo Texto
Lenguaje:English
Publicado: F1000 Research Limited 2018
Materias:
Method Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6081978/
https://www.ncbi.nlm.nih.gov/pubmed/30175246
http://dx.doi.org/10.12688/wellcomeopenres.14700.2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6081978/
https://www.ncbi.nlm.nih.gov/pubmed/30175246
http://dx.doi.org/10.12688/wellcomeopenres.14700.2

Ejemplares similares